Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $45.1 million.

  • Jaguar Health's Total Liabilities rose 520.02% to $45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.1 million, marking a year-over-year increase of 520.02%. This contributed to the annual value of $44.4 million for FY2024, which is 309.6% down from last year.
  • Jaguar Health's Total Liabilities amounted to $45.1 million in Q3 2025, which was up 520.02% from $41.4 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Total Liabilities registered a high of $49.3 million during Q1 2023, and its lowest value of $36.8 million during Q1 2021.
  • For the 5-year period, Jaguar Health's Total Liabilities averaged around $43.8 million, with its median value being $44.4 million (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 12091.43% in 2021, then tumbled by 1660.54% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Total Liabilities stood at $41.4 million in 2021, then grew by 17.86% to $48.8 million in 2022, then dropped by 6.03% to $45.9 million in 2023, then decreased by 3.1% to $44.4 million in 2024, then increased by 1.5% to $45.1 million in 2025.
  • Its last three reported values are $45.1 million in Q3 2025, $41.4 million for Q2 2025, and $48.1 million during Q1 2025.